CYTH - Cyclo Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CYTH is currently covered by 1 analysts with an average price target of $3.86. This is a potential upside of $2.6 (206.35%) from yesterday's end of day stock price of $1.26.

Cyclo Therapeutics's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of CYTH is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 49 days.

Highest price target for CYTH is $4, Lowest price target is $4, average price target is $3.86.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 27-Sep-2023. First documented stock forecast 17-Dec-2020.

Best performing analysts who are covering CYTH - Cyclo Therapeutics:

Jason Mccarthy

Currently out of the existing stock ratings of CYTH, 1 are a HOLD (50%), 1 are a BUY (50%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$2.59 (183.69%)

6 months 27 days ago

1/2 (50%)

$2.6 (185.71%)

49

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CYTH (Cyclo Therapeutics) average time for price targets to be met?

On average it took 49 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on CYTH (Cyclo Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on CYTH (Cyclo Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 2 price targets and 2 ratings on CYTH

Which analyst is the currently most bullish on CYTH (Cyclo Therapeutics)?

Jason Mccarthy with highest potential upside - $2.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?